Octarine Bio (private company)

See something wrong or missing? Let us know
Offices:Copenhagen
Business model:B2B

Octarine Bio is a synthetic biology company developing superior cannabinoid and psilocybin derivatives for the pharmaceutical industry.

Investors: we tracked 4 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 3M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Octarine Bio

Name Criteria
Denmark Synklino
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: Vækstfonden
  • Total raised in a similar range: 1M - 5M USD
Denmark MedTrace
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Vækstfonden
  • Total raised in a similar range: 1M - 5M USD
Denmark Fidabio
53%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: Vækstfonden
Denmark Subcuject
53%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: Vækstfonden
Denmark Levitate
53%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: Vækstfonden
Denmark Antag Therapeutics
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Vækstfonden
Denmark CathVision
53%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: Vækstfonden
Denmark Nanovi Radiotherapy A/S
53%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: Vækstfonden
Denmark Absolute Liquid Solutions
53%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: Vækstfonden
Denmark Freesense
53%
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: Vækstfonden
Top